Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.82 USD -5.68% Market Closed
Market Cap: 583.7m USD
Have any thoughts about
Mereo Biopharma Group PLC?
Write Note

Mereo Biopharma Group PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mereo Biopharma Group PLC
Capital Expenditures Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Capital Expenditures
ÂŁ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Capital Expenditures
-$169k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Capital Expenditures
-$11m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Capital Expenditures
-$916k
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Capital Expenditures
-ÂŁ5.4m
CAGR 3-Years
-21%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Capital Expenditures
-ÂŁ24.7m
CAGR 3-Years
10%
CAGR 5-Years
3%
CAGR 10-Years
-14%

See Also

What is Mereo Biopharma Group PLC's Capital Expenditures?
Capital Expenditures
0 GBP

Based on the financial report for Dec 31, 2023, Mereo Biopharma Group PLC's Capital Expenditures amounts to 0 GBP.

Back to Top